Related Experiment Video
Updated: Jun 21, 2026
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
D-ribose aids congestive heart failure patients
Heyder Omran1, Dean McCarter, John St Cyr
1Department of Medicine/Cardiology, University of Bonn, Bonn, Germany;
Experimental and Clinical Cardiology
|July 31, 2009
Summary
Ribose supplementation can improve diastolic function and enhance exercise capacity in patients with congestive heart failure, even with standard medical treatments. This finding offers a potential nutritional strategy to manage heart failure symptoms.
Area of Science:
- Cardiology
- Biochemistry
- Nutritional Science
Background:
- Congestive heart failure (CHF) frequently causes debilitating fatigue, impacting patient quality of life.
- Standard pharmacological treatments for CHF do not always resolve symptoms like fatigue and impaired cardiac function.
- Adenosine triphosphate (ATP) depletion is implicated in the pathophysiology of heart failure, affecting cardiac contractility and relaxation.
Purpose of the Study:
- To investigate the efficacy of ribose supplementation in improving diastolic function in patients with CHF.
- To assess the impact of ribose on the ischemic threshold and exercise tolerance in CHF patients.
- To explore ribose as an adjunct therapy for managing symptoms of congestive heart failure.
Main Methods:
- The study involved clinical trials with patients diagnosed with congestive heart failure.
- Participants received ribose supplementation as part of the intervention.
- Key outcome measures included diastolic function assessment, ischemic threshold determination, and evaluation of exercise capacity.
Main Results:
- Ribose supplementation was shown to aid in the recovery of ATP levels within cardiac tissues.
- Significant improvements in diastolic function were observed in patients receiving ribose.
- Clinical trials demonstrated an enhanced ischemic threshold and improved exercise tolerance with ribose supplementation.
Conclusions:
- Ribose supplementation represents a promising therapeutic approach for improving cardiac function in congestive heart failure.
- It may help mitigate fatigue and enhance the quality of life for CHF patients.
- Further research into ribose as a supportive therapy for heart failure is warranted.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...